Skip to content
Search

Latest Stories

PSNC presses for new approach to script switching

Pharmaceutical Services Negotiating Committee (PSNC) has raised concerns about the appropriateness of prescription switching during the Covid-19 pandemic.

Community pharmacy contractors have started to receive their FP34 Schedule of Payments relating to the dispensing of March and many have noticed a larger than usual number of switches listed.


During the pricing of prescriptions, if the pricing authority does not agree with the charge group (paid or exempt) in which a prescription has been submitted, the prescription will be ‘switched’.

If a declaration of exemption is required on the reverse of the form, but it has not been signed, the form is ‘switched’ to chargeable and a prescription charge is deducted from a contractor’s payment for each item on that form.

During the pandemic, many pharmacy teams have understandably been concerned about infection control, as per guidance issued by Public Health England (PHE) on the handling of paper prescriptions.

PSNC is pressing the DHSC and the NHS Business Services Authority (NHSBSA) to take a more pragmatic approach and review their processes around the switching of paper prescriptions with incomplete patient declarations.

PSNC has requested that such prescriptions are referred back to contractors or refunded.

Prior to the Covid-19 outbreak PSNC had proposed that all potential candidates for switching be referred back to the pharmacy for correction, however, this proposal was not accepted at the time.

Similarly, PSNC raised the collection of prescription charges during the Covid-19 pandemic as an unnecessary administrative burden and potential infection risk (through the handling of money) in discussions with the Government.

“We have also, with the British Medical Association (BMA) and Dispensing Doctors Association (DDA), written to the Secretary of State for Health and Social Care, Matt Hancock, to highlight this issue,” PSNC said.

“We will continue to press on both of these matters on behalf of community pharmacy contractors.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less